@article{ATM10455,
author = {Sabina Antoniu and Ruxandra Ulmeanu},
title = {Nivolumab for advanced non-small cell lung cancer: an immunologically-mediated tumor checkout},
journal = {Annals of Translational Medicine},
volume = {4},
number = {10},
year = {2016},
keywords = {},
abstract = {Non-small cell lung cancer (NSCLC) is associated with high mortality especially in the most advanced stages and when tumor is not responsive to the first line, conventional platinum-based chemotherapy or to newer compounds such as pemetrexed or erlotinib. Therefore newer agents with different mechanisms of action are needed and nivolumab is a relevant example of the kind.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/10455}
}